TD Cowen on Monday lowered its price target for oil and gas company Equinor (EQNR.OL) to 360 Norwegian kroner from 392 kroner and maintained its hold rating.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
Replimune Group (REPL) has an average rating of underweight and mean price target of $2.20, according to analysts polled by FactSet.Price: $10.99, Change: $-0.15, Percent Change: -1.30%
FuelCell Energy (FCEL) has an average rating of hold and mean price target of $18.83, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $23.44, Change: $+3.79, Percent Change: +19.26%
Analysts at Desjardins and Raymond James adjusted their price targets on Aecon Group (ARE.TO) to C$55 from C$52, and to C$52 from C$54, respectively, on Friday.On Thursday, Aecon announced its acquisition of Oaktree's convertible preferred equity investment in Aecon Utilities.Desjardins analyst Benoit Poirier maintained a Hold rating on shares of the Canadian construction and infrastructure development company."We support the transaction as Aecon now regains strategic and operational control of the full upside potential of the utilities business," Poirier said in a note to clients.Raymond James analyst Frederic Bastien maintained a Market Perform rating on the stock."While the implied $1.5 billion enterprise value for the utilities business was broadly in line with our valuation, the agreed cash consideration for Oaktree's stake exceeded our expectations, prompting us to lower our target price," the analyst said.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $44.71, Change: $+0.95, Percent Change: +2.17%